Datasheet | June 5, 2015

Cardio-Metabolic: Clinical Development and Consultative Services

Source: PRA Health Sciences

PRA Health Sciences (PRA) provides comprehensive clinical development and consultative services to support our clients’ cardio-metabolic studies. As the cornerstone of our cardio-metabolic disease program, our in-house team of therapeutic experts collaborate with our network of key opinion leaders and investigators, to mine insightful data and analyze how they will benefit our clients’ trials. Our experience spans more than 20 indications, and we have participated in the successful market approval of 6 cardio-metabolic drugs.

PRA's global investigator network has enabled us to establish preferred access to investigative sites that are able to accrue patients and deliver high-quality clinical trial data.

access the Datasheet!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)